TECX Q2 2023 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$11M

Net Income

-$10M

EPS (Diluted)

$18.29

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$259,000

Free Cash Flow

-$473,000

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$134M

Total Liabilities

$12M

Stockholders' Equity

$122M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$354,000	+100.0%
Operating Income	-$11M	-$28M	+61.7%
Net Income	-$10M	-$28M	+62.7%